PTHrP P3 promoter activity in breast cancer cell lines: Role of Ets1 and CBP (CREB binding protein)

Molecular and Cellular Endocrinology

Volumn 268, Issue 1-2, 2007, Pages 75-84

  Hamzaoui, Hinda ^a,b   Rizk Rabin, Marthe ^a,b   Gordon, Jonthan ^c   Offutt, Carlos ^c   Bertherat, Jérôme ^a,b   Bouizar, Zhor ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c Indiana University School of Medicine   (United States)

Author keywords

Breast cancer; Coactivators; PTHrP promoter; Transcription factors; Transcriptional regulation

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ETS1 PROTEIN; GENE PRODUCT; P3 PROMOTER PROTEIN; PARATHYROID HORMONE RELATED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; GENE ACTIVATION; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRUS E1A PROTEINS; ANIMALS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHICKENS; CREB-BINDING PROTEIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MOLECULAR SEQUENCE DATA; PARATHYROID HORMONE-RELATED PROTEIN; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANS-ACTIVATION (GENETICS);

EID: 33947194762     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.01.014     Document Type: Article

References (57)

1. Aittomaki S., Pesu M., Groner B., Janne O.A., Palvimo J.J., and Silvennoinen O. Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J. Immunol. 164 (2000) 5689-5697
2. Arias J., Alberts A.S., Brindle P., Claret F.X., Smeal T., Karin M., Feramisco J., and Montminy M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370 (1994) 226-229
3. Bassuk A.G., and Leiden J.M. A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3 (1995) 223-237
4. Bassuk A.G., Anandappa R.T., and Leiden J.M. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J. Virol. 71 (1997) 3563-3573
5. Berthon P., Goubin G., Dutrillaux B., Degeorges A., Faille A., Gespach C., and Calvo F. Single-steep transformation of human breast epithelial cells by SV40 large T oncogene. Int. J. Cancer 52 (1992) 92-97
6. Block K.L., Shou Y., and Poncz M. An Ets/Sp1 interaction in the 5′-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood 88 (1996) 2071-2080
7. Blumenthal S.G., Aichele G., Wirth T., Czernilofsky A.P., Nordheim A., and Dittmer J. Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1. J. Biol. Chem. 274 (1999) 12910-12916
8. Bouizar Z., Spyratos F., Deytieux S., de Vernejoul M.C., and Jullienne A. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res. 53 (1993) 5076-5078
9. Bouizar Z., Spyratos F., and De vernejoul M.C. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis. J. Bone Miner. Res. 14 (1999) 406-414
10. Broadus A.E., and Stewart A.F. Parathyroid hormone-related protein structure, processing and physiological actions. In: Bilezikian J.P. (Ed). The Parathyroids (1994), Raven Press, New York
11. Bundred N.J., Walker R.A., Ratcliffe W.A., Warwick J., Morrison J.M., and Ratcliffe J.G. Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur. J. Cancer 28 (1992) 690-692
12. Campos R.V., Wang C., and Drucker D.J. Regulation of parathyroid hormone-related peptide (PTHrP) gene transcription: cell- and tissue-specific promoter utilization mediated by multiple positive and negative cis-acting DNA elements. Mol. Endocrinol. 6 (1992) 1642-1652
13. Cataisson C., Lieberherr M., Cros M., Gauville C., Graulet A.M., Cotton J., Calvo F., de Vernejoul M.C., Foley J., and Bouizar Z. Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells. J. Bone Miner. Res. 15 (2000) 2129-2139
14. Cataisson C., Gordon J., Roussiere M., Abdalkhani A., Lindemann R., Dittmer J., Foley J., and Bouizar Z. Ets-1 activates parathyroid hormone-related protein gene expression in tumorigenic breast epithelial cells. Mol. Cell Endocrinol. 204 (2003) 155-168
15. Chilco P.J., Gerardi J.M., Kaczmarczyk S.J., Chu S., Leopold V., and Zajac J.D. Calcitonin increases transcription of parathyroid hormone-related protein via cAMP. Mol. Cell Endocrinol. 94 (1993) 1-7
16. Chilco P.J., Leopold V., and Zajac J.D. Differential regulation of the parathyroid hormone-related protein gene P1 and P3 promoters by cAMP. Mol. Cell Endocrinol. 138 (1998) 173-184
17. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., and Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365 (1993) 855-859
18. Delannoy-Courdent A., Fauquette W., Dong-Le Bourhis X.F., Boilly B., Vandenbunder B., and Desbiens X. Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. Int. J. Dev. Biol. 40 (1996) 1097-1108
19. Dittmer J., Pise-Masison C.A., Clemens K.E., Choi K.S., and Brady J.N. Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter. J. Biol. Chem. 272 (1997) 4953-4958
20. Fitzsimmons D., Hodsdon W., Wheat W., Maira S.M., Wasylyk B., and Hagman J. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10 (1996) 2198-2211
21. Foley J., Wysolmerski J.J., Missero C., King C.S., and Philbrick W.M. Regulation of parathyroid hormone-related protein gene expression in murine keratinocytes by E1A isoforms: a role for basal promoter and Ets-1 site. Mol. Cell. Endocrinol. 156 (1999) 13-23
22. Foulds C.E., Nelson M.L., Blaszczak A.G., and Graves B.J. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol. Cell Biol. 24 (2004) 10954-10964
23. Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., Laudano A., Gazit A., Levitzki A., Kraker A., and Jove R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20 (2001) 2499-2513
24. Giebler H.A., Lemasson I., and Nyborg J.K. p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation. Mol. Cell Biol. 20 (2000) 4849-4858
25. Gillespie M.T., and Martin T.J. The parathyroid hormone-related protein gene and its expression. Mol. Cell Endocrinol. 100 (1994) 143-147
26. Gitlin S.D., Dittmer J., Shin R.C., and Brady J.N. Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1. J. Virol. 67 (1993) 7307-7316
27. Gonzalez G.A., and Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59 (1989) 675-680
28. Goodman R.H., and Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 (2000) 1553-1577
29. Guise T.A., Yin J.J., Taylor S.D., Kumagai Y., Dallas M., Boyce B.F., Yoneda T., and Mundy G.R. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 98 (1996) 1544-1549
30. Guise T.A., Yin J.J., Thomas R.J., Dallas M., Cui Y., and Gillespie M.T. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Bone 30 (2002) 670-676
31. Janknecht R., and Hunter T. Transcription. A growing coactivator network. Nature 383 (1996) 22-23
32. Jayaraman G., Srinivas R., Duggan C., Ferreira E., Swaminathan S., Somasundaram K., Williams J., Hauser C., Kurkinen M., Dhar R., Weitzman S., Buttice G., and Thimmapaya B. p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter. J. Biol. Chem. 274 (1999) 17342-17352
33. Karperien M., Farih-Sips H., Lowik C.W., de Laat S.W., Boonstra J., and Defize L.H. Expression of the parathyroid hormone-related peptide gene in retinoic acid-induced differentiation: involvement of ETS and Sp1. Mol. Endocrinol. 11 (1997) 1435-1448
34. Lebeau J., Gerbault-Seureau M., Lemieux N., Apiou F., Calvo F., Berthon P., Goubin G., and Dutrillaux B. Loss of chromosome 3p arm differentiating tumorigenic from non-tumorigenic cells derived from the same SV40-transformed human mammary epithelial cells. Int. J. Cancer 60 (1995) 244-248
35. Lindemann R.K., Ballschmieter P., Nordheim A., and Dittmer J. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J. Biol. Chem. 276 (2001) 46661-46670
36. Mangin M., Webb A.C., Dreyer B.E., Posillico J.T., Ikeda K., Weir E.C., Stewart A.F., Bander N.H., Milstone L., Barton D.E., et al. Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc. Natl. Acad. Sci. USA 85 (1988) 597-601
37. Mangin M., Ikeda K., Dreyer B.E., and Broadus A.E. Identification of an up-stream promoter of the human parathyroid hormone-related peptide gene. Mol. Endocrinol. 4 (1990) 851-858
38. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2 (2001) 599-609
39. Murray T.M., Rao L.G., Divieti P., and Bringhurst F.R. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. Endocr. Rev. 26 (2005) 78-113
40. Oikawa T., and Yamada T. Molecular biology of the Ets family of transcription factors. Gene 303 (2003) 11-34
41. Papoutsopoulou S., and Janknecht R. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol. Cell Biol. 20 (2000) 7300-7310
42. Quinn C.O., Rajakumar R.A., and Agapova O.A. Parathyroid hormone induces rat interstitial collagenase mRNA through Ets-1 facilitated by cyclic AMP response element-binding protein and Ca(2+)/calmodulin-dependent protein kinase II in osteoblastic cells. J. Mol. Endocrinol. 25 (2000) 73-84
43. Rameil P., Lecine P., Ghysdael J., Gouilleux F., Kahn-Perles B., and Imbert J. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells. Oncogene 19 (2000) 2086-2097
44. Richard V., Luchin A., Brena R.M., Plass C., and Rosol T.J. Quantitative evaluation of alternative promoter usage and 3′ splice variants for parathyroid hormone-related protein by real-time reverse transcription-PCR. Clin. Chem. 49 (2003) 1398-1402
45. Richard V., Nadella M.V., Green P.L., Lairmore M.D., Feuer G., Foley J.G., and Rosol T.J. Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma. Leukemia 19 (2005) 1175-1183
46. Sementchenko V.I., and Watson D.K. Ets target genes: past, present and future. Oncogene 19 (2000) 6533-6548
47. Southby J., O'Keeffe L.M., Martin T.J., and Gillespie M.T. Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours. Br. J. Cancer 72 (1995) 702-707
48. Southby J., Murphy L.M., Martin T.J., and Gillespie M.T. Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormone-related protein. Endocrinology 137 (1996) 1349-1357
49. Suva L.J., Mather K.A., Gillespie M.T., Webb G.C., Ng K.W., Winslow G.A., Wood W.I., Martin T.J., and Hudson P.J. Structure of the 5′ flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP). Gene 77 (1989) 95-105
50. Thomas R.J., Guise T.A., Yin J.J., Elliott J., Horwood N.J., Martin T.J., and Gillespie M.T. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140 (1999) 4451-4458
51. Vasavada R.C., Wysolmerski J.J., Broadus A.E., and Philbrick W.M. Identification and characterization of a GC-rich promoter of the human parathyroid hormone-related peptide gene. Mol. Endocrinol. 7 (1993) 273-282
52. Wang H., Fang R., Cho J.Y., Libermann T.A., and Oettgen P. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J. Biol. Chem. 279 (2004) 25241-25250
53. Wang Y., Yang J., Gao Y., Du Y., Bao L., Niu W., and Yao Z. Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells. Cell. Mol. Immunol. 2 (2005) 365-372
54. Wardle F.C., Wainstock D.H., and Sive H.L. Cement gland-specific activation of the Xag1 promoter is regulated by co-operation of putative Ets and ATF/CREB transcription factors. Development 129 (2002) 4387-4397
55. Wasylyk B., Hahn S.L., and Giovane A. The Ets family of transcription factors. Eur. J. Biochem. 211 (1993) 7-18
56. Yang C., Shapiro L.H., Rivera M., Kumar A., and Brindle P.K. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol. Cell. Biol. 18 (1998) 2218-2229
57. Yin J.J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Wieser R., Massague J., Mundy G.R., and Guise T.A. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103 (1999) 197-206